MS
Michael E Schick
VP, Sales and Marketing

Michael E Schick insider trades: Allos Therapeutics (ALTH) stock sales

VP, Sales and Marketing, Allos Therapeutics Last trade Jul 11, 2012 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2011
1
Company
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 11, 2012ALTH↓ Sell10b5-1$1K
Mar 1, 2012ALTH↓ Sell10b5-1$12K
Feb 23, 2012ALTH↓ Sell10b5-1$3K
Nov 16, 2011ALTH↓ Sell10b5-1$12K
Jul 11, 2011ALTH↓ Sell10b5-1$2K
Feb 23, 2011ALTH↓ Sell10b5-1$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael E Schick's insider trades

Michael E Schick is VP, Sales and Marketing at Allos Therapeutics (ALTH). Since Feb 23, 2011, Michael has reported no open-market purchases and 6 sales worth $34K on SEC Form 4. There have been no open-market trades in the last 12 months.

6 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.